1Greenlee RT,Hi Harmon MB,Murray T,et al.Cancer statistics.CA Cancer J Clin,2001,51,15-36.
2Laufer M,Ranalingom S,Schoenberg MP,et al.Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder phase I and pharmacokinetic study.J Clin Oncol,2003,21:697-703.
3Bostwick DG,Ramnani D,Cheng L.Diagnosis and grading of bladder cancer and associated lesions.Urol Clin North Am,1999,26:493-507.
4Chang BS,Kim HL,Yang XJ,et al.Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.Urology,2001,57:1063-1066.
5Herr HW.Pathologic evaluation of radical cystectomy specimens.Cancer,2002,95:668-669.
6Prout GR,Barton BA,Griffin PP,et al.Treated history of noninvasive grade 1 rtansitional cell carcinoma.The National Bladder Cancer Group.J Urol,1992,148:1413-1419.
7Ebele JN,,Sauter G,Epstein JI,et al.Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs[]..2004
8Milln-Rodr姫quez F,,Chchile-Tomiolo G,Salvador-Bayarri J,et al.Multivariate analysis of the prognostic factors of primary superficial bladder cancer[].Journal d Urologie.2000
9Pich A,Chiusa L,Formiconi A,et al.Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade(grade1)papillary carcinomas of the bladder[].The American Journal of Surgical Pathology.2001
10Kaasinen E,Rintala E,Hellstr m P,et al.Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma[].European Urology.2002
